Table 2.
Patient baseline characteristics
| Patient number | Age (years) | Gender | Baseline CD4 (cells/μL) | Week of TB treatment when DVT diagnosed | Symptoms of bleeding | Co-medicationa |
|---|---|---|---|---|---|---|
| 1 | 30 | M | 6 | 1.5 | No | CTX, Fluconazole |
| 2 | 26 | M | 73 | 4 | No | CTX |
| 3 | 40 | F | 40 | 2 | Epistaxis | CTX |
| 4 | 39 | M | 72 | 10 | No | CTX |
| 5 | 27 | M | 78 | 2 | Epistaxis | CTX, fluconazole |
| 6 | 31 | M | 19 | 4 | No | CTX |
| 7 | 28 | M | 180 | 2 | No | CTX, fluconazole |
M male, F female, CTX cotrimoxazole
aAll patients were on tenofovir, lamivudine and efavirenz